SecBot SecBot

POCI

PRECISION OPTICS CORPORATION, INC.
Nasdaq· Electromedical & Electrotherapeutic Apparatus· Inc. MA· CIK 0000867840 Healthcare & Medical Devices
$4.35 +0.02 (+0.46%)
Oct 26 4:00 PM ET · prev $4.33
Market cap
$46.4M
Nano cap
Median target
$8.00
+84% · range $8.00–8.00
Next earnings
Nov 16
in 20 days · EPS est. −$0.13
1 year
+3.1%
from $4.22 · Oct 27
30 days
−4.0%
from $4.53
52-week range
$3.90–5.96
−27% from high · low Apr 7
Avg volume 20D
39.0K
Sep 29 spike 248.9K
Short interest
🔒 Subscribers only
Insider net
+$230.0K
3 buyers · 0 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
5
analyzed by SecBot
SecBot read MIXED 2 reports · 90 days
Balance 0 bearish · 0 bullish · 1 mixed · 1 neutral oldest → newest, height = score
Avg score ·High conf. 1/2 ·Next Earnings date, Nov 16, 2026
Strongest MIXED Precision Optics reported Q4 FY2026 revenue of $8.8M (+42% YoY) and EPS of -$0.01, beating consensus…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    3 insiders bought $230.0K at an average $3.60. No open-market sales. Price is 21% above their cost.

  • InstitutionsBULLISH

    Q2 2026: 5 added (0 new), 2 trimmed or exited.

  • EstimatesFALLING

    Current-quarter EPS estimate −$0.070 → −$0.130 over 90 days.

  • TrendDOWNTREND

    1% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
VANGUARD CAPITAL MANAGEMENT LLCADD325,751$1.7M
HighTower Advisors, LLCADD124,343$634.1K
CITADEL ADVISORS LLCADD41,735$212.8K
VANGUARD FIDUCIARY TRUST COADD38,747$197.6K
BlackRock, Inc.ADD27,084$138.1K
NORTHERN TRUST CORPTRIM14,633$74.6K
UBS Group AGTRIM387$2.0K
MORGAN STANLEYADD143,794$631.3K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

12-month targets · 1 analysts

Price is below the lowest target. Median implies +84%.Targets as of Oct 27, 2026.

Insider ledger

Form 4
$230.0K
bought · 3 insiders
$0
sold · 0 insiders
+20.8%
vs their $3.60 cost
DateInsiderTypeValue
Sep 30, 2026
COLL WAYNE M
Chief Financial Officer
AWARD$6.3K
Sep 30, 2026
COLL WAYNE M
Chief Financial Officer
AWARD$27.7K
Sep 21, 2026
COLL WAYNE M
Chief Financial Officer
AWARD6,742 sh
Sep 21, 2026
Forkey Joseph Norman
Chief Executive Officer
AWARD6,742 sh
Sep 21, 2026
TRAUT JOSEPH
Chief Operating Officer
AWARD6,742 sh
Aug 18, 2026
Thier Peter Richard
Senior VP - Sales & Marketing
AWARD50,000 sh
Jun 30, 2026
COLL WAYNE M
Chief Financial Officer
AWARD$6.2K
Mar 31, 2026
COLL WAYNE M
Chief Financial Officer
AWARD$6.2K

Earnings setup

Estimates
Nov 16
reports in 20 days
−$0.13
EPS estimate, this quarter
−86%
estimate change, 90 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.13-$0.13–-$0.13-85.7%$6.4M
Next Q-$0.10-$0.10–-$0.10-233.3%$7.0M
Current FY-$0.30-$0.30–-$0.30-328.6%$31.5M
Next FY$0.03$0.03–$0.03-85.7%$35.7M

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 30, 2026 Insider
COLL WAYNE M was granted 1,412 shares
Chief Financial Officer @ $4.43 ($6.3K)
Sep 30, 2026 Insider
COLL WAYNE M was granted 6,250 shares
Chief Financial Officer @ $4.43 ($27.7K)
Sep 28, 2026 SEC
Precision Optics reported Q4 FY2026 revenue of $8.8M (+42% YoY) and EPS of -$0.01, beating consensus estimates of…
PRESS-RELEASE — Impact 5/10
Sep 28, 2026 Earnings
Precision Optics Reports Fourth Quarter and Fiscal Year 2026 Financial Results
Conference Call Scheduled for Today, September 28, 2026, at 5:00 p.m. ET Conference Call Scheduled f
Sep 23, 2026 SEC
Precision Optics Corporation announced it will host a conference call on September 28, 2026 to discuss its fiscal Q4…
PRESS-RELEASE — Impact 1/10
Sep 21, 2026 Insider
COLL WAYNE M was granted 6,742 shares
Chief Financial Officer
Aug 26, 2026 Event
Morphine Sulfate
WARNING: SERIOUS AND LIFE-THREATENING RISKS FROM USE OF MORPHINE SULFATE ORAL SOLUTION Risk of Medic
Jun 30, 2026 Inst.
VANGUARD CAPITAL MANAGEMENT LLC — ADD
325,751 shares ($1.7M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 16, 2026
Earnings date
POCI Q1 2027 Earnings Scheduled — 2026-11-16
Recent
Sep 28, 2026
Earnings
Precision Optics Reports Fourth Quarter and Fiscal Year 2026 Financial Results
Conference Call Scheduled for Today, September 28, 2026, at 5:00 p.m. ET Conference Call Scheduled for Today, September 28, 2026, at 5:00 p.m. ET
Sep 28, 2026
Earnings result
POCI Q4 2026 Earnings: EPS $-0.01 (+83.7% vs est)
Sep 24, 2026
Earnings date
POCI Q4 2026 Earnings Scheduled — 2026-09-24
Sep 23, 2026
Earnings
Precision Optics Schedules Fourth Quarter and Fiscal Year 2026 Conference Call for September 28, 2026
LITTLETON, Mass., Sept. 23, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and…
Aug 26, 2026
FDA
Morphine Sulfate
WARNING: SERIOUS AND LIFE-THREATENING RISKS FROM USE OF MORPHINE SULFATE ORAL SOLUTION Risk of Medication Errors Ensure accuracy when prescribing, dis

SecBot reports

5 filings · 2 press releases · 2 bullish · 0 bearish · 1 mixed · 2 neutral
All POCI filing & press-release reports (7)